Discover the best database migration solutions for 2026. Compare cloud, custom, and fast options with real cost calculations ...

Importing MySQL databases into FileMaker Pro offers a quick-start to the development of new workgroup solutions.

Discover the leading database management systems for enterprises in 2026. Explore key features, pricing, and implementation tips for selecting the best DBMS software to harness your data effectively.

Microsoft reported on cloud, AI and security growth on its Q2 earnings report, setting itself and the channel up for ...

For developers working with SQL Server, few performance tuning techniques are as essential--or as frequently misunderstood--as indexing. Done right, indexing can drastically improve application ...

Update, Jan 13th, 2026: Multiple Target employees have now confirmed in our follow-up report the authenticity of leaked source code sample set and shared internal announcements regarding an access ...

Key benefits of Windows Server IoT for edge and industrial applications; how virtualization reduces hardware footprint and simplifies workload management; edition and licensing options tailored for ...

Good afternoon, and thank you for joining us today. On the call with me are Satya Nadella, Chairman and Chief Executive Officer; Amy Hood, Chief Financial Officer; Alice Jolla, Chief Accounting ...

Here's a look at the most recent Patch Tuesday release from Microsoft as well as a collection of recent updates so you can track what's changed. Long before Taco Tuesday became part of the pop-culture ...

Learn everything you need to know about two of the leading cloud-based infrastructure as a service providers, including how ...

WSUS is deprecated, leaving IT teams with an outdated, high-maintenance tool lacking third-party support and remote capabilities. This guide explains WSUS limitations, compares it to modern patching, ...

Artificial-intelligence-powered drug developer Insilico Medicine is set for a $10 million upfront payment from a fresh-faced Chinese biotech for half of the rights to a brain-penetrant NLRP3 inhibitor ...